TY  - JOUR

T1  - Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790.

JO  - Int J Cancer

PY  - 2009/09/01

AU  - Hald A

AU  - Hansen RR

AU  - Thomsen MW

AU  - Ding M

AU  - Croucher PI

AU  - Gallagher O

AU  - Ebetino FH

AU  - Kassem M

AU  - Heegaard A-M

ED  - 

DO  - DOI: 10.1002/ijc.24436

VL  - 125

IS  - 5

SP  - 1177

EP  - 1185

Y2  - 2024/12/22

ER  -